[큐캐피탈 밸류업]③ 에어스메디컬·한강화학·아이리스브라이트, 기대주 쑥쑥 큰다

AersMedical's projected $1.5-3 billion valuation and NASDAQ IPO plans validate the deeptech investment thesis, while Hangang Chemical demonstrates how regulatory changes like refrigerant quotas create hidden arbitrage opportunities generating steady profits. This blended portfolio strategy—combining speculative deeptech bets with high-margin cash generators like Iris Bright—is becoming critical for PE funds seeking to deliver both exponential growth and predictable returns to LPs navigating economic uncertainty.